Micafungin Sodium Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-09-11 · last update 2026-09-11
Manufacturers: Par Health, USA LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Micafungin Sodium, Injection, 10 mg/1 mL (NDC 42023-229-10) | Par Health, USA LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 09/11/2026 Updated 09/11/2026 Discontinued 09/11/2026 |
| Micafungin Sodium, Injection, 20 mg/1 mL (NDC 42023-230-10) | Par Health, USA LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 09/11/2026 Updated 09/11/2026 Discontinued 09/11/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)